ArticleAntimicrobial resistance and infection control2026
Evaluation of piperacillin-tazobactam appropriateness and underlying drivers of inappropriate prescribing in a Belgian University Hospital: a retrospective study.
Article in Antimicrobial resistance and infection control, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundVarying from 30% to 50% depending on the study, the high rate of inappropriate antimicrobial prescriptions is a major concern. These inappropriate prescriptions contribute to antibiotic resistance and associated morbidity and mortality. Prospective audit and feedback interventions is one of the core strategies recommended by the Infectious Diseases Society of America to improve antibiotic use. In line with this guidance, this approach was selected to evaluate piperacillin-tazobactam (PTZ) use within our institution.
methodsA prospective audit of PTZ prescribing was conducted over an 11-week period at the CHU of Liège. Prescriptions were reviewed weekly by an infectious diseases specialist and a clinical hospital pharmacist. The primary outcome was the appropriateness of PTZ prescriptions across three main evaluation criteria -indication, spectrum and duration- and one minor criterion -notification of the indication in the medical records-. The secondary outcome was to identify potential drivers of inappropriate prescribing. Interventions involved antibiotic discontinuation, de-escalation, oral step-down therapy and optimizing the pharmacokinetic and pharmacodynamic (PK/PD) profile.
resultsOverall, 91.8% of the prescriptions were deemed appropriate for indication, 74.5% for spectrum, and 50% for duration. Notification was adequate in 65.5% of cases. However, most prescriptions were empirical (nearly 90%). Regarding stewardship interventions, broad-spectrum antibiotics were discontinued or de-escalated in 33.6% and 19.1% of cases, respectively, with intravenous-to-oral switch and PK/PD optimization suggested in 17.3% and 11.8% of cases. Our study identified several statistically significant determinants of inappropriate antibiotic use, including the type of care unit and the Charlson Comorbidity Index.
conclusionsOur findings point out the role of an antimicrobial stewardship program in improving antibiotic use, especially in surgical units where inappropriate indication and poor notification were most common. Importantly, antibiotic treatment duration remains problematic across all hospital units. By linking patient characteristics to outcomes, our study identifies key drivers of inappropriate use, which could be further confirmed and refined in future research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.